Cornell Pochily Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Cornell Pochily Investment Advisors's NVS Position: Q2 2026 in Review
Cornell Pochily Investment Advisors sold out of Novartis (NVS) in Q2 2026, closing a stake of 1,402 shares — an estimated $214K sold.
Cornell Pochily Investment Advisors first reported a position in NVS in Q4 2017 and held it in 22 quarters. The position peaked at $324K in Q1 2019. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Cornell Pochily Investment Advisors reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
- Cornell Pochily Investment Advisors sold 1,402 Novartis shares in Q2 2026, an estimated $214K.
- Cornell Pochily Investment Advisors first reported a position in Novartis in Q4 2017 and held it in 22 quarters.
- Cornell Pochily Investment Advisors's Novartis position peaked at $324K in Q1 2019.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.